Arena Pharmaceuticals, Inc.
ARNANASDAQHealthcare
$99.99
+$0.00(+0.00%)
Market Cap$0
P/E Ratio—
52W High$100
52W Low$99.97
Arena Pharmaceuticals, Inc. (ARNA) · Income Statement
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · ARNA · as of 2026-06-09
Financial statements
Revenue · Gross Profit · Net Income
| Breakdown | 2021-12 | 2020-12 | 2019-12 | 2018-12 | 2017-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $0.05M | $0.32M | $806.43M | $17.97M | $21.34M |
| Cost of Revenue | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Gross Profit | $0.05M | $0.32M | $806.43M | $17.97M | $21.34M |
| Gross Margin %(computed) | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% |
| Operating Expenses | |||||
| R&D Expenses | $419.51M | $323.74M | $231.50M | $115.03M | $70.99M |
| G&A Expenses | $126.20M | $103.20M | $77.60M | $47.70M | $30.30M |
| Total Operating Expenses | $554.35M | $426.94M | $323.67M | $162.73M | $101.29M |
| Operating Income | ($612.27M) | ($426.64M) | $482.75M | ($144.78M) | ($91.97M) |
| Operating Margin %(computed) | — | — | 59.86% | -805.69% | -431.02% |
| Interest Income | $1.43M | $11.05M | $26.87M | $8.77M | $0.49M |
| Interest Expense | $4.16M | $4.52M | $4.79M | $5.70M | $6.12M |
| Income Before Tax | ($616.43M) | ($404.73M) | $507.89M | ($138.83M) | ($95.81M) |
| Income Tax Expense | $4.16M | $0.00M | $110.33M | ($110.27M) | $2.27M |
| Net Income | ($620.59M) | ($404.73M) | $397.56M | ($29.40M) | ($91.41M) |
| Net Margin %(computed) | — | — | 49.30% | -163.60% | -428.40% |
| Per Share & EBITDA | |||||
| EPS (Basic) | $-11.33 | $-7.39 | $7.69 | $-0.62 | $-2.77 |
| Wtd Avg Shares | 54.77M | 54.77M | 51.70M | 47.04M | 32.99M |
| EBITDA | ($608.40M) | ($396.35M) | $515.91M | ($130.21M) | ($81.01M) |
| EBITDA Margin %(computed) | — | — | 63.97% | -724.60% | -379.67% |
Data source: Financial Modeling Prep · Last updated: 2026-06-09 · USD · M
Explore more Arena Pharmaceuticals, Inc. data
About Arena Pharmaceuticals, Inc. (ARNA) Income Statement
Arena Pharmaceuticals, Inc. (ARNA) income statement data is sourced from SEC Form 10-K and 10-Q filings. For fiscal year 2021, ARNA reported revenue of $0.00B, gross profit of $0.00B (gross margin 100.00%), and net income of ($0.62B) — a net profit margin of -1149244.44%.
Frequently asked questions
ARNA · 4 questionsArena Pharmaceuticals, Inc. (ARNA) reported revenue of $0.00B for 2021, down 83.1% year-over-year.
ARNA revenueARNA salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-09